介入放射学方法用于癌症药物反应的原位评估:临床前开发、可行性与安全性
这项前瞻性临床前可行性与安全性研究于2022年3月至2024年10月在12只携带单侧后肢VX2肿瘤的兔中经介入方式置入和取出可植入微装置(IMD),每只动物置入4或5个IMD,每个IMD在24-48小时内向18个空间独立的微观肿瘤区域递送三种药物(多柔比星、拓扑替康、舒尼替尼)的微剂量;技术成功率为100%(12/12;95%CI:73.5,100),总体区域级取出成功率为65%(608/936;95%CI:62,68),未观察到CTCAE 2级或以上不良事件。
要点
- 兔VX2肿瘤模型中经介入方式置入和取出IMD技术可行且安全,技术成功率为100%。
- 区域级取出成功率为65%,每只动物平均取出50.7个区域。
- 未观察到CTCAE 2级或以上不良事件,2只动物发生IMD脱落后滞留于肿瘤内(1级)。
核心结论
- 在兔软组织肿瘤模型中,经介入方式置入和取出IMD在技术上可行且安全,该方法能够回收多个药物暴露区域用于局部药物效应的原位评估。
研究设计与样本
- 前瞻性临床前可行性与安全性研究,于2022年3月至2024年10月进行,纳入12只携带单侧后肢VX2肿瘤的兔,每只动物置入4或5个IMD,采用经导丝活检操作取出IMD及周围肿瘤。
诊断标准与关键数值
- 技术成功定义为每只动物至少取出一个含有全部三种药物(多柔比星、拓扑替康、舒尼替尼)的肿瘤区域,技术成功率为100%(12/12;95%CI:73.5,100);总体区域级取出成功率为65%(608/936;95%CI:62,68)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To evaluate the technical feasibility and safety of a nonsurgical interventional method for placement and retrieval of implantable microdevices (IMDs) in a rabbit tumor model. Materials and Methods This prospective preclinical feasibility and safety study was conducted from March 2022 to October 2024. Interventional IMD placement and retrieval were performed in 12 rabbits with single hindlimb VX2 tumors. Four or five IMDs were placed per animal. Each IMD delivered microdose quantities of three drugs (doxorubicin, topotecan, sunitinib) into 18 spatially distinct microscopic tumor regions over 24-48 hours. An over-the-wire biopsy procedure was used to extract the IMDs and surrounding tumor. Technical success was defined per animal as retrieval of at least one tumor region containing each of the three drugs. Overall region-level retrieval success rate was calculated as the overall percentage of drug-exposed regions retrieved successfully. Safety was determined by monitoring animals for adverse events. Procedure durations were assessed to inform clinical translation. Statistical analysis included calculation of binomial 95% CIs for success rates and summary statistics (mean ± SD) for region yield and procedure times. Results Twelve rabbits received 52 IMDs (mean, 4.3 ± 0.5 per animal) generating 936 drug-exposure sites. Technical success was 100% (12 of 12; 95% CI: 73.5, 100). Mean per animal retrieval was 50.7 regions ± 11.4 (range, 33-69), with an overall region-level success rate of 65% (608 of 936; 95% CI: 62, 68). No Common Terminology Criteria for Adverse Events grade 2 (moderate) or higher adverse events were observed. In two animals, IMDs dislodged from the guidewire and were retained in the tumor; no symptoms developed, and no additional intervention was required (grade 1). Implantation procedure duration was 30.3 minutes ± 5.3 and retrieval procedure duration was 49.1 minutes ± 6.3. Conclusion Interventional IMD placement and retrieval in a rabbit soft tissue tumor model was technically feasible and safe. This approach demonstrated the capacity to recover multiple drug-exposed regions for in situ assessment of local drug effects. Keywords: Implantable Microdevice, Personalized Treatment, Percutaneous Biopsy, Phase 0 Trials, Microdosing, Interventional Radiology Supplemental material is available for this article. © RSNA, 2025.
引用
- Bhagavatula SK, Reichert R, Ahn SW, et al. An Interventional Radiology Method for In Situ Assessments of Cancer Drug Response: Preclinical Development, Feasibility, and Safety. Radiol Imaging Cancer. 2025. PMID: 40879481. doi:10.1148/rycan.250055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。